Výsledky vyhledávání - "Ryusuke, Ono"

Akademický článek

Clinical trial on the efficacy and safety of NPC-15 for patients with xeroderma pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for a multicentre, double-blinded, placebo-controlled, two-group crossover study followed by a long-term open study in Japan

Autor: Sae Murakami, Shinichi Moriwaki, Yasumasa Kakei, Chikako Nishigori, Mariko Tsujimoto, Nozomi Yamano, Takeshi Fujita, Takehiro Ueda, Ryusuke Ono

Publikováno v: BMJ Open, Vol 13, Iss 3 (2023)

Introduction Xeroderma pigmentosum (XP) is a rare intractable disease without a fundamental treatment, presenting with severe photosensitivity, freckle-like pigmented and depigmented maculae and numerous skin cancers before the age of 10 years withou

Externí odkaz: https://doaj.org/article/d11cba17fda1448db1a236ec2b8d72be

Zobrazit plný text záznamu

Akademický článek

A case of xeroderma pigmentosum group C with rare compound heterozygous mutations.

Autor: Kozo KAWAGUCHI, Makiko KIDO-NAKAHARA, Yoko KUBA-FUYUNO, Gaku TSUJI, Ryusuke ONO, Chikako NISHIGORI, Takeshi NAKAHARA

Publikováno v: European Journal of Dermatology; mar/apr2024, Vol. 34 Issue 2, p226-228, 3p

Zobrazit plný text záznamu

Autor: Seiji, Takeuchi, Toshiro, Matsuda, Mariko, Tsujimoto, Takeshi, Fukumoto, Ryusuke, Ono, Chikako, Nishigori

Publikováno v: Journal of Dermatological Science. 105:152-158

Xeroderma pigmentosum (XP) is hereditary disorder characterized by photosensitivity, predisposition to skin cancers of sun-exposed body sites and progressive neurologic symptoms in some cases. Cells from XP patients show higher sensitivity to ultravi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3ba63f183503ede3c3a0a2d56b9f7c
https://doi.org/10.1016/j.jdermsci.2022.01.009

Zobrazit plný text záznamu

Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria

Autor: Rikuma Kitao, Yoshiko Oda, Ken Washio, Yukimasa Tai, Ryusuke Ono, Chikako Nishigori, Atsushi Fukunaga

Publikováno v: The Journal of dermatologyREFERENCES. 49(7)

Omalizumab is known to be effective in treating chronic spontaneous urticaria (CSU) with an inadequate response to H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ef4a79855be3253cbb4014e6e79fa3b
https://pubmed.ncbi.nlm.nih.gov/35352836

Zobrazit plný text záznamu

Whole-exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity

Autor: Makoto Sugaya, Ryusuke Ono, Shinichi Sato, Yusuke Okuno, Kaoru Funamizu, Taisuke Kondo, Masashi Akiyama, Michihiro Kono, Chikako Nishigori

Publikováno v: The Journal of dermatologyREFERENCES. 48(1)

A case of xeroderma pigmentosum (XP) group D in a 39-year-old Japanese man is reported. The patient had suffered from moderate to severe solar sensitivity and freckle-like pigmented macules in sun-exposed areas since 6 years of age, and developed ski

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e778344f5f76740700bb0adf8db866d9
https://pubmed.ncbi.nlm.nih.gov/32974964

Zobrazit plný text záznamu

The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale

Autor: Taro Masaki, Seiji Takeuchi, Chikako Nishigori, Shinichi Moriwaki, Eiji Nakano, Ryusuke Ono, Fumio Kanda

Publikováno v: Experimental Dermatology. 25:28-33

Xeroderma pigmentosum (XP) is a rare autosomal recessive hereditary disease. Patients with XP have severe hypersensitivity to sunlight, resulting in skin cancers, and some patients have neurological symptoms. In Japan, XP complementation group A (XP-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dedbaf94c5fcae7beb6357b0c4a29a5
https://doi.org/10.1111/exd.13082

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání